Lymphedema Arm
28
8
13
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.6%
1 terminated out of 28 trials
90.0%
+3.5% vs benchmark
4%
1 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (28)
Advancing Patient Care for Lymphatic Pain and Lymphedema
Mobile Self-Management Training for Lymphedema Prevention
Screening For BCRL In Targeted Therapy For Breast Cancer
Preoperative Indocyanine Green Lymphography and High-Frequency Ultrasound as Predictors of Lymphaticovenous Anastomosis Outcome in Post-Mastectomy Upper Limb Lymphedema
Extracellular Fluid Changes During Neoadjuvant Chemotherapy
Prehabilitation in Breast Cancer Surgery
Clinical Evaluation of a Device for Treatment of Lymphedema of the Upper Extremity
The N-LVA Study: RCT Comparing LVA vs. Sham Surgery in Cancer-related Lymphedema
Lymphedema Sensor Technology Development Study
Evaluation of Combination Therapy for Upper Extremity Lymphedema
Integrating Clinical, Protein Expression, and Genetic Markers to Predict Lymphedema in Breast Cancer
Lymphovenous Bypass Procedure for Secondary Prevention of Lymphedema in Breast Cancer
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
Effectiveness of a Therapeutic Exercise Program With Specific Upper Limb Exercises to Reduce Lymphedema and Neuropathy in Breast Cancer Patients: A Pre-post Study (LYNMA)
Adjustable Compression Wraps (ACW) in Lymphedema
Lymphovenous Anastomosis for Breast Cancer Lymphedema
LymphoPilot Test for Limb Lymphedema
The Effectiveness of Lymphatic Bypass Supermicrosurgery
Efficacy of Home-based Treatment for Breast Cancer-related Lymphedema
Reduction of Arm Volume and Improvement in Lymphedema Via Surgery